We believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. We also believe that AI is a tool, not an identity – without access to high-quality data and a scientifically rigorous, transparent approach to model development, AI is just a buzzword. That's where we come in.
Aignostics is a spin-off from one of Europe's largest and most prestigious university hospitals (Charité), with employees in Berlin and New York. We have received over $50M in funding from leading investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading global life sciences companies.
Data Science or Machine Learning? We do both at Aignostics, and are convinced that both are needed for success. You can expect to work on a broad spectrum of topics from deep learning with foundation and other state-of-the-art models on terabytes of data to projects in low sample regimes and very high-dimensional and multimodal data. We have nearly all the data science challenges you can think of for you!
APCT1_DE